Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of pancuronium during therapeutic hypothermia after cardiac arrest
NL-OMON23344Not yet recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pancuronium in cardiac arrest (SCA), sponsored by Maastricht University Medical Center+. Primary endpoint: Median duration until TOF ratio 0.9 after pancuronium discontinuation. Planned start Dec 2011; status: not yet recruiting.
02
Drugs
pancuronium
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NL-OMON23344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23344.